| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.2M | +50.6% |
| Cost of Revenue | $15.4M | +193.1% |
| Gross Profit | $771K | -85.9% |
| R&D Expense | $10.8M | +127.0% |
| SG&A Expense | $27.7M | +73.3% |
| Operating Income | -$43.0M | -182.2% |
| Pre-tax Income | -$61.9M | -253.2% |
| Net Income | -$61.9M | -253.2% |
| EPS (Basic) | -$1.56 | -1633.3% |
| EPS (Diluted) | -$1.56 | -1633.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.3M | -55.4% |
| Accounts Receivable | $2.1M | +4.6% |
| Inventory | $581K | +6.5% |
| Current Assets | $25.6M | -25.2% |
| Total Assets | $129.0M | +104.9% |
| Current Liabilities | $6.3M | +34.5% |
| Total Liabilities | $7.4M | +33.8% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$44.9M | -158.8% |
| Capital Expenditures | $3.0M | +420.8% |
| Investing Cash Flow | -$89.1M | -312.5% |
| Financing Cash Flow | $117.4M | +73.8% |
| Free Cash Flow | -$47.9M | -167.2% |
| $121.6M |
| +111.8% |